The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Improved Pregnancy Outcomes for Women with SLE

Improved Pregnancy Outcomes for Women with SLE

August 19, 2019 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Systemic lupus erythematosus (SLE) primarily affects women of childbearing age and is more likely to be diagnosed in women of color. Historically, physicians have counseled women with SLE to avoid becoming pregnant and to terminate the pregnancy if they become pregnant. However, the past two decades have resulted in treatment approaches that have reduced the mortality rates from SLE and lupus nephritis. During this same time, rheumatologists have implemented major changes in the management of pregnant women with SLE.

You Might Also Like
  • Lupus Pregnancy Outcomes Improved Over the Past 2 Decades
  • Pregnancy Outcomes in Women with Idiopathic Inflammatory Myositis
  • Promote Pregnancy Wellness: Data Can Help Guide Pregnancy Management in Lupus
Also By This Author
  • Hepatitis C Virus Infection Associated with Rheumatoid Arthritis

Results from a large study indicate in-hospital maternal mortality and overall pregnancy outcomes have improved markedly over the past 18 years for women with SLE, as well as those without SLE. Bella Mehta, MBBS, a rheumatologist at the Hospital for Special Surgery, New York City, and colleagues performed the analysis, concluding that although improvements in pregnancy outcomes have been particularly noteworthy in women with SLE, SLE pregnancy risks still remain high. The authors published their findings online July 9 in the Annals of Internal Medicine.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The study included a nationwide sample of hospitalized pregnant women from the National Inpatient Sample (NIS) and compared data from 1998–2000 with data from 2013–2015. The NIS contains discharge data from approximately 20% of all community hospitals in the U.S. but does not include outpatient information, such as outpatient deliveries, early pregnancy losses and miscarriages. The researchers found the percentage of pregnant patients with SLE increased significantly from 0.09% of all pregnancy-related admissions in the first period to 0.16% in the second, indicating that more women with SLE are attempting pregnancy.

In the first data period, the investigators documented in-hospital mortality in patients with SLE at 442 per 100,000 admissions. They found this rate declined dramatically to less than 50 per 100,000 admissions during the second data period. Likewise, in the first data period, SLE patients had an in-hospital mortality rate 34 times higher than patients without SLE, while the second data period revealed that the in-hospital maternal mortality rate had declined to five times higher for women with SLE than for women without SLE. The preeclampsia/eclampsia rates in patients with SLE also decreased between the same two periods from 9.5% to 9.1%, and fetal mortality rates for all women declined, but were not statistically significant.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Our findings confirm other data showing that SLE pregnancies are associated with a greater [length of stay] and higher hospital charges. In our study, total hospitalization charges were 1.8 times higher for women with SLE than for those without,” write the authors in their discussion. “Non-delivery related hospitalizations decreased, but remained more frequent in SLE pregnancies, although [length of stay] decreased. A possibility exists that more efficient in-hospital care for pregnant patients with SLE improved maternal and fetal outcomes while lowering [length of stay].”

Pages: 1 2 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: Outcomes, pregnancy, pregnancy complications, pregnant women, SLE, systemic lupus erythematosus (SLE)

You Might Also Like:
  • Lupus Pregnancy Outcomes Improved Over the Past 2 Decades
  • Pregnancy Outcomes in Women with Idiopathic Inflammatory Myositis
  • Promote Pregnancy Wellness: Data Can Help Guide Pregnancy Management in Lupus
  • A More Complicated Pregnancy: Inflammatory Arthritis Increases the Risk for Adverse Outcomes

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)